Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients.

Monica MieleRosalia BusàGiovanna RusselliMaria Concetta SorrentinoMariangela Di BellaFrancesca TimoneriAlessandra MularoniGiovanna PanarelloPatrizio VituloPier Giulio ConaldiMatteo Bulati

Published in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2021)

Keyphrases

immune response
sars cov
end stage renal disease
newly diagnosed
chronic kidney disease
prognostic factors
dendritic cells
patient reported outcomes
patient reported